RE: HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1

被引：2
作者：
Bertucci, Francois [1 ,2 ]
de Nonneville, Alexandre [1 ]
Finetti, Pascal [1 ]
Mamessier, Emilie [1 ]
机构：
[1] Aix Marseille Univ, Inst Paoli Calmettes, Lab Predict Oncol, INSERM U1068,CNRS UMR72,CRCM,Label Ligue Canc, Marseille, France
[2] Inst Paoli Calmettes, Dept Med Oncol, 232 Bd St Marguer, F-13009 Marseille, France
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2023年 / 115卷 / 06期
关键词：
D O I：
10.1093/jnci/djad060
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：762 / 763
页数：2
相关论文
共 7 条
[1]   HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1 [J].
Braso-Maristany, Fara ;
Griguolo, Gaia ;
Chic, Nuria ;
Pascual, Tomas ;
Pare, Laia ;
Maues, Julia ;
Galvan, Patricia ;
Dieci, Maria Vittoria ;
Miglietta, Federica ;
Giarratano, Tommaso ;
Martinez-Saez, Olga ;
Marin-Aguilera, Mercedes ;
Schettini, Francesco ;
Conte, Benedetta ;
Angelats, Laura ;
Vidal, Maria ;
Adamo, Barbara ;
Munoz, Montserrat ;
Sanfeliu, Esther ;
Gonzalez, Blanca ;
Vivancos, Ana ;
Villagrasa, Patricia ;
Parker, Joel S. ;
Perou, Charles M. ;
Conte, PierFranco ;
Prat, Aleix ;
Guarneri, Valentina .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (03) :332-336
[2]   Tumor biomarkers and efficacy in patients treated with trastuzumab emtansine plus pertuzumab versus standard of care in HER2-positive early breast cancer: an open-label, phase III study (KRISTINE) [J].
de Haas, Sanne L. ;
Slamon, Dennis J. ;
Martin, Miguel ;
Press, Michael F. ;
Lewis, Gail D. ;
Lambertini, Chiara ;
Prat, Aleix ;
Lopez-Valverde, Vanesa ;
Boulet, Thomas ;
Hurvitz, Sara A. .
BREAST CANCER RESEARCH, 2023, 25 (01)
[3]   A pathway-based classification of human breast cancer [J].
Gatza, Michael L. ;
Lucas, Joseph E. ;
Barry, William T. ;
Kim, Jong Wook ;
Wang, Quanli ;
Crawford, Matthew D. ;
Datto, Michael B. ;
Kelley, Michael ;
Mathey-Prevot, Bernard ;
Potti, Anil ;
Nevins, Joseph R. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (15) :6994-6999
[4]   ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines [J].
Ginestier, C. ;
Adelaiede, J. ;
Goncalves, A. ;
Repellini, L. ;
Sircoulomb, F. ;
Letessier, A. ;
Finetti, P. ;
Geneix, J. ;
Charafe-Jauffret, E. ;
Bertucci, F. ;
Jacquemier, J. ;
Viens, P. ;
Birnbaum, D. .
ONCOGENE, 2007, 26 (50) :7163-7169
[5]   ERBB2mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer [J].
Griguolo, Gaia ;
Braso-Maristany, Fara ;
Gonzalez-Farre, Blanca ;
Pascual, Tomas ;
Chic, Nuria ;
Sauri, Tamara ;
Kates, Ronald ;
Gluz, Oleg ;
Martinez, Debora ;
Pare, Laia ;
Tsvetkova, Vassilena ;
Pesantez, David ;
Vidal, Maria ;
Adamo, Barbara ;
Munoz, Montserrat ;
Galvan, Patricia ;
Barbera, Laura ;
Cuatrecasas, Miriam ;
Christgen, Mathias ;
Kreipe, Hans ;
Monge-Escartin, Ines ;
Villagrasa, Patricia ;
Soy, Dolors ;
Giarratano, Tommaso ;
Dieci, Maria Vittoria ;
Conte, Pierfranco ;
Harbeck, Nadia ;
Guarneri, Valentina ;
Prat, Aleix .
CANCERS, 2020, 12 (07) :1-25
[6]  
Prat A, 2020, LANCET ONCOL, V21, P1455, DOI 10.1016/S1470-2045(20)30450-2
[7]   Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies [J].
Wolf, Denise M. ;
Yau, Christina ;
Wulfkuhle, Julia ;
Brown-Swigart, Lamorna ;
Gallagher, Rosa, I ;
Lee, Pei Rong Evelyn ;
Zhu, Zelos ;
Magbanua, Mark J. ;
Sayaman, Rosalyn ;
O'Grady, Nicholas ;
Basu, Amrita ;
Delson, Amy ;
Coppe, Jean Philippe ;
Lu, Ruixiao ;
Braun, Jerome ;
Asare, Smita M. ;
Sit, Laura ;
Matthews, Jeffrey B. ;
Perlmutter, Jane ;
Hylton, Nola ;
Liu, Minetta C. ;
Pohlmann, Paula ;
Symmans, W. Fraser ;
Rugo, Hope S. ;
Isaacs, Claudine ;
DeMichele, Angela M. ;
Yee, Douglas ;
Berry, Donald A. ;
Pusztai, Lajos ;
Petricoin, Emanuel F. ;
Hirst, Gillian L. ;
Esserman, Laura J. ;
Veer, Laura J. van 't .
CANCER CELL, 2022, 40 (06) :609-+
1